$CLMB

Climb Global Solutions Reports Second Quarter 2026 Results

Climb Global Solutions (NASDAQ:CLMB) reported Q2 2026 results for the quarter ended June 30, 2026. Net sales rose 9% to $174.2M and gross billings increased 17% to $587.3M. Gross profit grew 15% to $30.2M. Net income was $5.5M, or $0.30 diluted EPS, vs $6.0M. Adjusted EBITDA was $11.3M. Cash was $56.6M and the company had no debt.

Original reporting
Published Jul 29, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 11:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CLMB
Neutral
medium confidence
Mentioned
$CLMB
Relevance
8/10
alphai data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$CLMBNeutralMed
01

Why it matters

Traders can reassess CLMB’s earnings quality given flat adjusted EBITDA and a sharp drop in effective margin, while also weighing stronger top-line and gross billings growth and improved cash balance with no debt.

02

Market read

The quarter provides a concrete earnings datapoint plus margin deterioration and cost/integration signals, with a near-term catalyst in the scheduled conference call.

03

What to watch

Gross billings growth (up 17%) outpaced net sales growth (up 9%), suggesting working-capital timing and mix effects could matter more than the headline margin in the next few quarters.

Relevance 8/10Novelty 7/10Timing: after-hours Q2 results, ahead of the July 30, 2026 8:30 a.m. ET conference call

Background

Climb is a value-added global IT channel company; this quarter includes contributions from its Interworks acquisition completed Feb. 24, 2026.

Company-level read

Ticker impact

$CLMBNeutralMedium confidence
Context

Climb reported Q2 2026 net sales up 9% to $174.2M and adjusted EBITDA $11.3M, with margin down to 37.5% from 43.3%.

Expected impact

Likely modest, two-sided reaction unless management commentary on margin recovery or Interworks integration offsets the margin compression.

Evidence & confidence

The release provides multiple hard datapoints (sales, gross billings, net income, adjusted EBITDA, effective margin, cash, and debt status) plus commentary on organic growth and acquisition contribution, but no explicit forward guidance numbers.

Market effects

Signals ongoing demand for IT channel/distribution services, but highlights cost and margin pressure risk during integration and scaling.

North America and Europe both contributed to gross profit growth, with Europe flagged as a key focus area.

Moderate relevance for global IT channel peers as it reflects acquisition-driven growth plus margin volatility.

Counterpoint

Margin compression may be temporary due to Interworks integration and higher legal/professional and IT infrastructure spend, so the market may over-penalize the quarter.

Key entities

  • Climb Global Solutions, Inc.

    NASDAQ-listed IT channel/distribution and solutions provider reporting Q2 2026 results.

  • Interworks

    Acquired Feb. 24, 2026, contributing to distribution segment gross billings and higher SG&A.

  • Dale Foster

    CEO quoted on organic growth, line-card strategy, and Investor Day messaging.

Related articles

$CLMBMed

Climb Global Solutions, Inc. (CLMB): Results of Operations and Financial Condition

Climb Global Solutions, Inc. (CLMB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_955763.htm EXHIBIT 99.1 ex_955763.htm Exhibit 99.1 Climb Global Solutions Reports Second Quarter 2026 Results Net Sales up 9% to $174.2 Million; Gross Billings up 17% to $587.3 Million; Gross Profit up 15% to $30.2 Million EATONTOWN, N.J., July 29, 2026 – Climb Globa

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.